Subscribe today!
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Posters
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
All Multimedia
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Posters
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
All Multimedia
Subscribe!
Subscribe Today!
Home
/
Tags
/
immune checkpoint inhibitors
immune checkpoint inhibitors
| 3 min read
by
Luisa Torres, PhD
A new major player in T cell suppression and tumor control
An inhibitory receptor binds a checkpoint protein to thwart T cell proliferation and function.
News
| 9 min read
by
Allison Whitten, PhD
Customizing mRNA vaccines for cancer
Researchers use mRNA to create cancer vaccines that are personalized to each individual’s unique tumor.
News
Available on Demand
by
Drug Discovery News
Combination therapy for cancer: using immunotherapy and viruses
How are scientists incorporating oncolytic viruses into the current cancer treatment landscape?
Webinars
| 6 min read
by
Luisa Torres, PhD
The dual role of microbiota in cancer immunotherapy
Understanding the complex three-way communication between immune cells, the gut microbiome, and cancer sheds light on why immunotherapies fail in some patients but succeed in others.
Articles
| 4 min read
by
Alejandra Manjarrez, PhD
How gut microbes meddle with cancer immunotherapy
By investigating how gut bacteria influence immunotherapy responses in mice, researchers found a molecule involved in treatment resistance.
Articles
| 3 min read
by
Iris Kulbatski, PhD
Advancing immune forces at the tumor frontlines
Epigenetic therapies revive the immune cell offensive in immunotherapy resistant tumors.
News
Page 1 of 1 - 6 Total Items
1
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe
Sponsored
Driving gene therapy with nonviral vectors
Learn why nonviral vectors are on the rise in gene therapy development.
Posters
Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis
Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Milestones
Advancing immuno-oncology research with cellular assays
Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Webinars
Latest Issue
Volume 20 • Issue 6 • November 2024
November 2024
November 2024 Issue
Explore this issue